Indegene Limited has informed the Exchange regarding re-appointment of Dr. Georgia Nikolakopoulou Papathomas as Non- Executive Independent Director of the company w.e.f. October 01, 2025, subject to approval of shareholders at the ensuing Annual General Meeting.
INDGN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indegene Limited has announced the re-appointment of Dr. Georgia Nikolakopoulou Papathomas as a Non-Executive Independent Director, effective October 01, 2025. The re-appointment is subject to approval from shareholders at the company's upcoming Annual General Meeting. Dr. Papathomas will continue to serve in an independent capacity on the board. This is a routine corporate governance action to ensure board continuity.
This is a routine governance update with no material impact on the stock price. It maintains continuity on the board of directors, which is generally viewed positively by investors.